Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases

S Jain, M Nehra, R Kumar, N Dilbaghi, TY Hu… - Biosensors and …, 2021 - Elsevier
On global scale, the current situation of pandemic is symptomatic of increased incidences of
contagious diseases caused by pathogens. The faster spread of these diseases, in a …

Tracking virus outbreaks in the twenty-first century

ND Grubaugh, JT Ladner, P Lemey, OG Pybus… - Nature …, 2019 - nature.com
Emerging viruses have the potential to impose substantial mortality, morbidity and economic
burdens on human populations. Tracking the spread of infectious diseases to assist in their …

Point-of-care diagnostics: recent developments in a connected age

S Nayak, NR Blumenfeld, T Laksanasopin… - Analytical …, 2017 - ACS Publications
The field of point-of-care (POC) diagnostics offers the tantalizing possibility of providing
rapid diagnostic results in nonlaboratory settings. Here, we review progress in this research …

Point of care testing for infectious diseases

H Chen, K Liu, Z Li, P Wang - Clinica chimica acta, 2019 - Elsevier
Infectious diseases are caused by pathogenic microorganisms and can be transmitted
between individuals and populations thus threatening the general public health and …

Portable biosensing devices for point-of-care diagnostics: Recent developments and applications

M Zarei - TrAC Trends in Analytical Chemistry, 2017 - Elsevier
Low-cost point-of-care (POC) diagnostics play several critical roles in healthcare strategies,
particularly for detection, therapy, economy, health management, and surveillance. Any user …

A serological point-of-care test for the detection of IgG antibodies against Ebola virus in human survivors

P Brangel, A Sobarzo, C Parolo, BS Miller, PD Howes… - ACS …, 2018 - ACS Publications
Ebola virus disease causes widespread and highly fatal epidemics in human populations.
Today, there is still great need for point-of-care tests for diagnosis, patient management and …

Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea

D Sissoko, C Laouenan, E Folkesson… - PLoS …, 2016 - journals.plos.org
Background Ebola virus disease (EVD) is a highly lethal condition for which no specific
treatment has proven efficacy. In September 2014, while the Ebola outbreak was at its peak …

Diagnosis of Ebola virus disease: past, present, and future

MJ Broadhurst, TJG Brooks… - Clinical microbiology …, 2016 - Am Soc Microbiol
Laboratory diagnosis of Ebola virus disease plays a critical role in outbreak response efforts;
however, establishing safe and expeditious testing strategies for this high-biosafety-level …

Field-effect transistor biosensor for rapid detection of Ebola antigen

Y Chen, R Ren, H Pu, X Guo, J Chang, G Zhou… - Scientific reports, 2017 - nature.com
The Ebola virus transmits a highly contagious, frequently fatal human disease for which
there is no specific antiviral treatment. Therefore, rapid, accurate, and early diagnosis of …

[HTML][HTML] Ebola virus disease: An emerging and re-emerging viral threat

M Rojas, DM Monsalve, Y Pacheco… - Journal of …, 2020 - Elsevier
The genus Ebolavirus from the family Filoviridae is composed of five species including
Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and …